Sales & Marketing Sponsored Company Profile: Aktiia Hypertension is known to be one of the most prevalent chronic health conditions globally.
News Heart disease risk ‘calculator’ could save lives UK researchers say they have developed an algorithm that is more accurate than current tools at predicting an individual’s risk of developing cardiovascular disease in the
R&D The race for obesity drug assets heats up The existing treatments for weight loss have drawn interest from across the industry, as their efficacy and sales potential become evident.
Market Access Nine for 2024, Pt 1: From fragility to resilience This year was a year of significant new beginnings for pharma and healthcare, yet, it was still impacted by the long-term fallouts of the pandemic.
Patients The paradox of cardiovascular disease: Out in the open, but ... When prompted with the question, ’What is the world’s deadliest disease?’, what would be your first guess?
News Semaglutide scores again, this time in heart failure The list of benefits for Novo Nordisk's semaglutide keeps getting longer.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
